NO933505L - Fosfolipid-derivater som inneholder höyere elementer fra hovedgruppe V - Google Patents

Fosfolipid-derivater som inneholder höyere elementer fra hovedgruppe V

Info

Publication number
NO933505L
NO933505L NO933505A NO933505A NO933505L NO 933505 L NO933505 L NO 933505L NO 933505 A NO933505 A NO 933505A NO 933505 A NO933505 A NO 933505A NO 933505 L NO933505 L NO 933505L
Authority
NO
Norway
Prior art keywords
containing higher
phospholipid derivatives
derivatives containing
major group
higher elements
Prior art date
Application number
NO933505A
Other languages
English (en)
Other versions
NO305911B1 (no
NO933505D0 (no
Inventor
Gerhard Nossner
Jurij Stekar
Peter Hilgard
Bernhard Kutscher
Jurgen Engel
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of NO933505D0 publication Critical patent/NO933505D0/no
Publication of NO933505L publication Critical patent/NO933505L/no
Publication of NO305911B1 publication Critical patent/NO305911B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/72—Aliphatic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO933505A 1992-10-01 1993-09-30 Fosfolipid-derivater som inneholder höyere elementer fra hovedgruppe V, fremgangsmåte for fremstilling derav samt legemiddel inneholdende forbindelsen NO305911B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4233044A DE4233044A1 (de) 1992-10-01 1992-10-01 Phospholipidderivate, die höhere Elemente der V. Hauptgruppe enthalten

Publications (3)

Publication Number Publication Date
NO933505D0 NO933505D0 (no) 1993-09-30
NO933505L true NO933505L (no) 1994-04-05
NO305911B1 NO305911B1 (no) 1999-08-16

Family

ID=6469408

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933505A NO305911B1 (no) 1992-10-01 1993-09-30 Fosfolipid-derivater som inneholder höyere elementer fra hovedgruppe V, fremgangsmåte for fremstilling derav samt legemiddel inneholdende forbindelsen

Country Status (23)

Country Link
US (2) US5449798A (no)
EP (1) EP0594999B1 (no)
JP (1) JP3688304B2 (no)
KR (1) KR100331367B1 (no)
CN (1) CN1055697C (no)
AT (1) ATE174030T1 (no)
AU (1) AU661795B2 (no)
BR (1) BR9303990A (no)
CA (1) CA2107439C (no)
DE (2) DE4233044A1 (no)
DK (1) DK0594999T3 (no)
EG (1) EG20258A (no)
ES (1) ES2125935T3 (no)
FI (1) FI111261B (no)
GR (1) GR3029423T3 (no)
HU (1) HU220593B1 (no)
IL (1) IL107141A (no)
MX (1) MX9306076A (no)
NO (1) NO305911B1 (no)
PH (1) PH29951A (no)
RU (1) RU2126413C1 (no)
UA (1) UA39163C2 (no)
ZA (1) ZA937282B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP026997A0 (en) 1997-11-07 1997-12-04 Resmed Limited Administration of cpap treatment pressure in presence of apnea
US20060116354A1 (en) * 2003-01-09 2006-06-01 Perkins Walter R Antineoplastic ether lipid compounds with modifications at the sn-3 carbon
AR058397A1 (es) 2005-12-19 2008-01-30 Zentaris Gmbh Derivados de alquilfosfolipidos con citotoxicidad reducida y usos de los mismos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177216A (en) * 1974-06-21 1979-12-04 The Dow Chemical Company Novel tributyl (2,5-dihydroxyphenyl)phosphonium hydroxide inner salts
US4177716A (en) * 1978-02-21 1979-12-11 Gerald J. Bowe Automatic energy saver and fire damper for exhaust systems
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
EP0916343A1 (de) * 1989-09-27 1999-05-19 ASTA Medica Aktiengesellschaft Verwendung von Alkylphosphorsäure-Verbindungen zur Bekämpfung von Psoriasis-Erkrankungen
DE3942933A1 (de) * 1989-12-23 1991-06-27 Boehringer Mannheim Gmbh Verwendung von alkylphospholipiden als antivirale arzneimittel und neue phospholipid-derivate
DE4111105A1 (de) * 1991-04-05 1992-10-08 Max Planck Gesellschaft Neue erucyl-, brassidyl- und nervonylderivate

Also Published As

Publication number Publication date
ZA937282B (en) 1994-04-25
FI934297A (fi) 1994-04-02
HU9302772D0 (en) 1993-12-28
CN1055697C (zh) 2000-08-23
US5637577A (en) 1997-06-10
IL107141A0 (en) 1993-12-28
NO305911B1 (no) 1999-08-16
NO933505D0 (no) 1993-09-30
EP0594999A1 (de) 1994-05-04
EP0594999B1 (de) 1998-12-02
BR9303990A (pt) 1994-06-14
DE59309182D1 (de) 1999-01-14
HUT65681A (en) 1994-07-28
CA2107439A1 (en) 1994-04-02
AU661795B2 (en) 1995-08-03
CA2107439C (en) 2006-08-15
JPH06199876A (ja) 1994-07-19
HU220593B1 (hu) 2002-03-28
KR940009201A (ko) 1994-05-20
AU4874793A (en) 1994-04-14
PH29951A (en) 1996-09-16
MX9306076A (es) 1994-05-31
GR3029423T3 (en) 1999-05-28
RU2126413C1 (ru) 1999-02-20
ES2125935T3 (es) 1999-03-16
IL107141A (en) 1998-01-04
FI111261B (fi) 2003-06-30
JP3688304B2 (ja) 2005-08-24
DE4233044A1 (de) 1994-04-07
DK0594999T3 (da) 1999-08-16
US5449798A (en) 1995-09-12
UA39163C2 (uk) 2001-06-15
FI934297A0 (fi) 1993-09-30
ATE174030T1 (de) 1998-12-15
KR100331367B1 (ko) 2002-11-13
EG20258A (en) 1998-05-31
CN1088583A (zh) 1994-06-29

Similar Documents

Publication Publication Date Title
EP0595133A3 (de) Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
FI942074A (fi) nor-sappijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
IL88900A0 (en) Imidazoles,their preparation and pharmaceutical compositions containing them
WO1991018866A3 (en) 1,4-diamino-2,3-dihydroxybutanes
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NO933505L (no) Fosfolipid-derivater som inneholder höyere elementer fra hovedgruppe V
IL106289A0 (en) Phospholipid derivatives, their preparation and pharmaceutical compositions containing them
ZA866487B (en) Methylendioxyphenanthren-and stilben derivatives,processes for the preparation thereof and pharmaceutical compositions containing these compounds
NO179312C (no) Anv. av minst en forb. valgt fra gruppen omfattende et salt av S-adenosyl-L-metionin,5-metyltetrahydrofolinsyre og 5-formyltetrahydrofolinsyre el.saltene derav som den aktive bestanddel til fremst.av et farmasöyt.prep. samt det farmasöyt.prep.